A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
Phase 3
Completed
- Conditions
- Cervical CancerGenital Warts
- Interventions
- Biological: HPV (Human Papillomavirus) Vaccine
- First Posted Date
- 2007-07-13
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- Simon Dobson
- Target Recruit Count
- 830
- Registration Number
- NCT00501137
- Locations
- 🇨🇦
Vaccine Evaluation Centre, Vancouver, British Columbia, Canada
© Copyright 2025. All Rights Reserved by MedPath